Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terbinafine Treatment of Axial Spondyloarthropathy

NCT05119712 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05119712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terbinafine Treatment of Axial Spondyloarthropathy
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Withdrawn
Start date
March 9, 2021
Completion date
October 15, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, axial spondyloarthopathy, axial spondyloarthritis, psoriatic spondylitis, spondylitis secondary to inflammatory bowel disease